Concepedia

Phase III, randomised trial of avelumab versus physician’s choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300

Yu Jeong Bang, Eduardo Yañez Ruiz, Eric Van Cutsem, Kuhn‐Uk Lee, Lucjan Wyrwicz, Michael Schenker, María Alsina, Min‐Hee Ryu, Hyun Cheol Chung, Ludovic Evesque,

Annals of Oncology · 2018 · 503 citations · 15 references

DOIFull text

Open access

Concepts

References

15

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations

, , +14

SEER Cancer Statistics Review, 1975-2003

Lynn A. G. Ries, D. Harkins, Martin Krapcho et al. · ScholarWorks - Georgia State University (Georgia State University) · 2006 · 11.5K citations · Full text

, , +12

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Yung‐Jue Bang, Eric Van Cutsem, A. Feyereislova et al. · The Lancet · 2010 · 7.3K citations · Full text

, , +17

Comprehensive molecular characterization of gastric adenocarcinoma

Adam J. Bass, Vésteinn Thórsson, David Van Den Berg et al. · Nature · 2014 · 6.5K citations · Full text

, , +17

Japanese gastric cancer treatment guidelines 2014 (ver. 4)

Gastric Cancer · 2016 · 2.5K citations · Full text

, , +10